ASMB — ASSEMBLY BIOSCIENCES, INC.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.
Performance
Technicals
Others in Healthcare
Measured signals that fired on ASMB
| date | signal | measured base rate |
|---|---|---|
| 2026-06-11 | Short volume far above its own normal short | -0.76% over 21 days · t = -2.79 · n = 5,897 statistically distinguishable from its control group |
| 2026-05-21 | Equal lows taken out structure | -0.64% over 21 days · t = -4.75 · n = 55,661 statistically distinguishable from its control group |
| 2026-05-13 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-03-05 | Short volume far above its own normal short | -0.76% over 21 days · t = -2.79 · n = 5,897 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-06-17 | Bjorkquist Jeanette M PFO and PAO | Open-market sale | 29 | 23.25 | 674 |
| 2026-05-26 | GILEAD SCIENCES, INC. 10% owner | Grant or award | 471.7K | 26.50 | 12.5M |
| 2026-03-30 | Bjorkquist Jeanette M PFO and PAO | Open-market sale | 312 | 26.65 | 8.3K |
| 2026-03-30 | White Nicole S Chief Manufacturing Officer | Open-market sale | 188 | 26.65 | 5.0K |
| 2026-03-30 | Bjorkquist Jeanette M PFO and PAO | Open-market sale | 16 | 27.49 | 440 |
| 2026-03-30 | White Nicole S Chief Manufacturing Officer | Open-market sale | 9 | 27.49 | 247 |
| 2026-03-29 | Gaggar Anuj Chief Medical Officer | Grant or award | 14.0K | 0.00 | 0 |
| 2026-03-29 | Delaney William E IV Chief Scientific Officer | Grant or award | 14.0K | 0.00 | 0 |
| 2026-03-29 | Delaney William E IV Chief Scientific Officer | Grant or award | 26.0K | 0.00 | 0 |
| 2026-03-29 | White Nicole S Chief Manufacturing Officer | Grant or award | 14.0K | 0.00 | 0 |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| GILEAD SCIENCES, INC. | 125.0M | 4.5M |
| FARALLON CAPITAL MANAGEMENT LLC | 34.1M | 1.2M |
| RA CAPITAL MANAGEMENT, L.P. | 28.3M | 1.0M |
| Commodore Capital LP | 27.8M | 1.0M |
| JANUS HENDERSON GROUP PLC | 23.5M | 849.3K |
| Paradigm Biocapital Advisors LP | 18.5M | 665.3K |
| VANGUARD CAPITAL MANAGEMENT LLC | 13.6M | 490.4K |
| Parkman Healthcare Partners LLC | 11.4M | 411.2K |
| STEMPOINT CAPITAL LP | 10.3M | 370.9K |
| Point72 Asset Management, L.P. | 9.5M | 344.1K |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| SCHEDULE 13G/A | 2026-08-14 | — | on EDGAR ↗ |
| 8-K/A | 2026-08-14 | 2026-08-13 | on EDGAR ↗ |
| 10-Q | 2026-08-13 | 2026-06-30 | on EDGAR ↗ |
| 8-K | 2026-08-13 | 2026-08-13 | on EDGAR ↗ |
| SCHEDULE 13G/A | 2026-08-13 | — | on EDGAR ↗ |
| SCHEDULE 13G/A | 2026-08-04 | — | on EDGAR ↗ |
| 4 | 2026-06-18 | 2026-06-17 | on EDGAR ↗ |
| 4 | 2026-06-05 | 2026-03-29 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Assembly Biosciences, Inc. (ASMB) filed form 8-K/A · 2026-08-14 · SEC EDGAR
- Assembly Biosciences, Inc. (ASMB) filed form 8-K · 2026-08-13 · SEC EDGAR
Ask the AI about ASMB
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →